Delivery Order SPE2DR25D3501-SPE2DR26FM2BZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,055.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was not set aside for any specific business category and represents a competitively awarded contract. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,414.68 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $2,475.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a ceiling value of $1,102.92. The contract is structured as a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,563.20 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen Drug Corp's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded a delivery order valued at $5,213.92 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,700.95 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.80 to AmerisourceBergen Drug Corp for erythromycin 0.5% eye ointment, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger pharmaceutical supply relationship with DLA....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,888.66, represents a competitive award with no set-aside designation and carries an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2BZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,084.30 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This firm fixed-price delivery order, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a non-set-aside, competitively awarded contract. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen Drug Corp's corporate office. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor providing critical medical supplies to federal government agencies. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/8/26 |